Scale & Diversity
Value Through Partnership
UK: becoming a beacon destination for clinical trials
Experts in recruiting patients and running clinical trials - an exemplar SMO model
"We are a team of experienced clinical trial specialists who have held very senior roles in organisations which have pioneered the recruitment and running of clincial trials across the world."
Dr. Ian Smith
Founder of Synexus & Co-Founder of Panthera Biopartners
Our dedicated Panthera clinical trial sites located across the UK.
We have a huge reach in Britain's highest populated cities:
Patient testimonials
Latest Panthera News
Panthera Biopartners appoints Martyn Jellett as Associate Director Business Development to support growing commercial team
Independent clinical trial SMO (Site Management Organisation) Panthera Biopartners has appointed Martyn Jellett as Associate Director Business Development to support its expanding commercial team as the company continues to prosper and expand. Martyn has over 25 years experience in professional sales and business development and has extensive knowledge of the pharmaceutical and medical industry. Panthera,
International Clinical Trials (ICT): Panthera interview
International Clinical Trials (ICT): Panthera interview – Private vs public vaccine studies, how SMOs can secure the future of UK clinical trials Panthera’s Ian Smith and Chris Dodd recently spoke to ICT about the differences in private versus public clinical trials, how speed is key in preclinical processes and how the UK can improve its
Panthera bucks the trend and brings vaccine trials to the UK
Panthera Biopartners has become a world leader in running international vaccine studies. In the last 18 months, Panthera has run eight vaccine studies at its network of clinical trial sites across the UK on behalf of the pharma industry. Panthera’s sites are regularly first in the world or first in the UK in treating the